These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6247706)

  • 1. [Role of prolactin in the growth of prostatic neoplasms].
    Jeromin L
    Pol Tyg Lek; 1980 Mar; 35(12):453-4. PubMed ID: 6247706
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of prolactin in the male organism].
    Gladkova AI
    Urol Nefrol (Mosk); 1979; (5):64-9. PubMed ID: 532022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolactin and cancer of the prostate. I. Prolactin: biochemistry, control of its secretion and functions. Its role in androgen metabolism and in prostate physiology].
    Maganto Pavón E; Mateos Torres JA; Mayayo Dehesa T; Boronat Tormo F; Allona Almagro A; Escudero Barrilero A
    Arch Esp Urol; 1982; 35(2):79-88. PubMed ID: 6287948
    [No Abstract]   [Full Text] [Related]  

  • 4. Polypeptide hormones and the prostate.
    Webber MM
    Prog Clin Biol Res; 1981; 75B():63-88. PubMed ID: 6275414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of androgen-independent prostate cancer.
    Feldman BJ; Feldman D
    Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine control of prostate cancer.
    Wilding G
    Cancer Surv; 1995; 23():43-62. PubMed ID: 7621473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prostatic cell: structure and function. Part B. Prolactin, carcinogenesis, and clinical aspects.
    Prog Clin Biol Res; 1981; 75B():1-349. PubMed ID: 7323094
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.
    Tombal B
    Eur Urol; 2009 Feb; 55(2):321. PubMed ID: 18838209
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of testosterone in the pathogenesis of prostate cancer.
    Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Nihei N; Naya Y; Ichikawa T
    Int J Urol; 2008 Jun; 15(6):472-80. PubMed ID: 18430151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of growth factors in the pathogenesis of BPH.
    Habib FK
    Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412
    [No Abstract]   [Full Text] [Related]  

  • 11. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
    Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
    Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrate metabolism of normal and malignant prostate epithelial cells.
    Costello LC; Franklin RB
    Urology; 1997 Jul; 50(1):3-12. PubMed ID: 9218011
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth factors in the prostate.
    Wilson EM; Smith EP
    Prog Clin Biol Res; 1987; 239():205-33. PubMed ID: 3309956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonal and molecular biological factors in pathogenesis of prostate cancer].
    Zezerov EG
    Vopr Onkol; 2001; 47(2):174-81. PubMed ID: 11383453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to research on prostatic function and pathology.
    Purvis K; Rui H; Attramadal A; Tveter KJ
    Eur Surg Res; 1984; 16 Suppl 2():88-101. PubMed ID: 6202522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone Deficiency and the Prostate.
    Alukal JP; Lepor H
    Urol Clin North Am; 2016 May; 43(2):203-8. PubMed ID: 27132577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X; Kreye E; Kuo CB; Walker AM
    Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolactin receptors in the prostate].
    Wylot M; Laszczyńska M; Chorzepa K
    Pol Merkur Lekarski; 2006 Nov; 21(125):492-4. PubMed ID: 17345848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic hormones and prostate cancer risk: status and prospects.
    Gann PH
    IARC Sci Publ; 2002; 156():283-8. PubMed ID: 12484188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.